HealthLynked Corp.
HealthLynked Corp. HLYK Peers
See (HLYK) competitors and their performances in Stock Market.
Peer Comparison Table: Medical - Care Facilities Industry
Detailed financial metrics including price, market cap, P/E ratio, and more.
| Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
|---|---|---|---|---|---|---|
| HLYK | $0.03 | +13.12% | 7.05M | -1.25 | -$0.02 | N/A |
| FSNUY | $11.70 | -1.89% | 105.39B | 22.49 | $0.52 | N/A |
| RVLWF | $0.04 | +97.97% | 38.58B | -0.30 | -$0.13 | N/A |
| FSNUF | $37.73 | +10.48% | 21.25B | 20.85 | $1.81 | N/A |
| FMCQF | $52.25 | +37.14% | 15.33B | 21.86 | $2.39 | +2.48% |
| BDUUY | $32.33 | N/A | 12.84B | 28.36 | $1.14 | +2.79% |
| BDULF | $0.71 | -4.05% | 11.28B | 23.67 | $0.03 | +3.13% |
| BDUUF | $0.66 | -14.29% | 10.49B | 22.00 | $0.03 | +3.36% |
| JDHIY | $3.25 | +100.00% | 10.40B | 18.06 | $0.18 | N/A |
| JDHIF | $3.23 | N/A | 10.33B | 26.92 | $0.12 | N/A |
Stock Comparison
HLYK vs FSNUY Comparison
HLYK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HLYK stands at 7.05M. In comparison, FSNUY has a market cap of 105.39B. Regarding current trading prices, HLYK is priced at $0.03, while FSNUY trades at $11.70.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HLYK currently has a P/E ratio of -1.25, whereas FSNUY's P/E ratio is 22.49. In terms of profitability, HLYK's ROE is +4.66%, compared to FSNUY's ROE of +0.02%. Regarding short-term risk, HLYK is more volatile compared to FSNUY. This indicates potentially higher risk in terms of short-term price fluctuations for HLYK.
HLYK vs RVLWF Comparison
HLYK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HLYK stands at 7.05M. In comparison, RVLWF has a market cap of 38.58B. Regarding current trading prices, HLYK is priced at $0.03, while RVLWF trades at $0.04.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HLYK currently has a P/E ratio of -1.25, whereas RVLWF's P/E ratio is -0.30. In terms of profitability, HLYK's ROE is +4.66%, compared to RVLWF's ROE of +3.95%. Regarding short-term risk, HLYK is more volatile compared to RVLWF. This indicates potentially higher risk in terms of short-term price fluctuations for HLYK.
HLYK vs FSNUF Comparison
HLYK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HLYK stands at 7.05M. In comparison, FSNUF has a market cap of 21.25B. Regarding current trading prices, HLYK is priced at $0.03, while FSNUF trades at $37.73.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HLYK currently has a P/E ratio of -1.25, whereas FSNUF's P/E ratio is 20.85. In terms of profitability, HLYK's ROE is +4.66%, compared to FSNUF's ROE of +0.02%. Regarding short-term risk, HLYK is more volatile compared to FSNUF. This indicates potentially higher risk in terms of short-term price fluctuations for HLYK.
HLYK vs FMCQF Comparison
HLYK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HLYK stands at 7.05M. In comparison, FMCQF has a market cap of 15.33B. Regarding current trading prices, HLYK is priced at $0.03, while FMCQF trades at $52.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HLYK currently has a P/E ratio of -1.25, whereas FMCQF's P/E ratio is 21.86. In terms of profitability, HLYK's ROE is +4.66%, compared to FMCQF's ROE of +0.04%. Regarding short-term risk, HLYK is more volatile compared to FMCQF. This indicates potentially higher risk in terms of short-term price fluctuations for HLYK.
HLYK vs BDUUY Comparison
HLYK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HLYK stands at 7.05M. In comparison, BDUUY has a market cap of 12.84B. Regarding current trading prices, HLYK is priced at $0.03, while BDUUY trades at $32.33.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HLYK currently has a P/E ratio of -1.25, whereas BDUUY's P/E ratio is 28.36. In terms of profitability, HLYK's ROE is +4.66%, compared to BDUUY's ROE of +0.16%. Regarding short-term risk, HLYK is more volatile compared to BDUUY. This indicates potentially higher risk in terms of short-term price fluctuations for HLYK.
HLYK vs BDULF Comparison
HLYK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HLYK stands at 7.05M. In comparison, BDULF has a market cap of 11.28B. Regarding current trading prices, HLYK is priced at $0.03, while BDULF trades at $0.71.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HLYK currently has a P/E ratio of -1.25, whereas BDULF's P/E ratio is 23.67. In terms of profitability, HLYK's ROE is +4.66%, compared to BDULF's ROE of +0.16%. Regarding short-term risk, HLYK is more volatile compared to BDULF. This indicates potentially higher risk in terms of short-term price fluctuations for HLYK.
HLYK vs BDUUF Comparison
HLYK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HLYK stands at 7.05M. In comparison, BDUUF has a market cap of 10.49B. Regarding current trading prices, HLYK is priced at $0.03, while BDUUF trades at $0.66.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HLYK currently has a P/E ratio of -1.25, whereas BDUUF's P/E ratio is 22.00. In terms of profitability, HLYK's ROE is +4.66%, compared to BDUUF's ROE of +0.16%. Regarding short-term risk, HLYK is more volatile compared to BDUUF. This indicates potentially higher risk in terms of short-term price fluctuations for HLYK.
HLYK vs JDHIY Comparison
HLYK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HLYK stands at 7.05M. In comparison, JDHIY has a market cap of 10.40B. Regarding current trading prices, HLYK is priced at $0.03, while JDHIY trades at $3.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HLYK currently has a P/E ratio of -1.25, whereas JDHIY's P/E ratio is 18.06. In terms of profitability, HLYK's ROE is +4.66%, compared to JDHIY's ROE of +0.05%. Regarding short-term risk, HLYK is more volatile compared to JDHIY. This indicates potentially higher risk in terms of short-term price fluctuations for HLYK.
HLYK vs JDHIF Comparison
HLYK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HLYK stands at 7.05M. In comparison, JDHIF has a market cap of 10.33B. Regarding current trading prices, HLYK is priced at $0.03, while JDHIF trades at $3.23.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HLYK currently has a P/E ratio of -1.25, whereas JDHIF's P/E ratio is 26.92. In terms of profitability, HLYK's ROE is +4.66%, compared to JDHIF's ROE of +0.05%. Regarding short-term risk, HLYK is more volatile compared to JDHIF. This indicates potentially higher risk in terms of short-term price fluctuations for HLYK.
HLYK vs IHHHF Comparison
HLYK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HLYK stands at 7.05M. In comparison, IHHHF has a market cap of 9.70B. Regarding current trading prices, HLYK is priced at $0.03, while IHHHF trades at $1.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HLYK currently has a P/E ratio of -1.25, whereas IHHHF's P/E ratio is 15.71. In terms of profitability, HLYK's ROE is +4.66%, compared to IHHHF's ROE of +0.09%. Regarding short-term risk, HLYK is more volatile compared to IHHHF. This indicates potentially higher risk in terms of short-term price fluctuations for HLYK.
HLYK vs RMYHY Comparison
HLYK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HLYK stands at 7.05M. In comparison, RMYHY has a market cap of 5.62B. Regarding current trading prices, HLYK is priced at $0.03, while RMYHY trades at $6.09.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HLYK currently has a P/E ratio of -1.25, whereas RMYHY's P/E ratio is 609.00. In terms of profitability, HLYK's ROE is +4.66%, compared to RMYHY's ROE of +0.18%. Regarding short-term risk, HLYK is more volatile compared to RMYHY. This indicates potentially higher risk in terms of short-term price fluctuations for HLYK.
HLYK vs RMSYF Comparison
HLYK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HLYK stands at 7.05M. In comparison, RMSYF has a market cap of 5.06B. Regarding current trading prices, HLYK is priced at $0.03, while RMSYF trades at $22.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HLYK currently has a P/E ratio of -1.25, whereas RMSYF's P/E ratio is 440.00. In terms of profitability, HLYK's ROE is +4.66%, compared to RMSYF's ROE of +0.18%. Regarding short-term risk, HLYK is more volatile compared to RMSYF. This indicates potentially higher risk in terms of short-term price fluctuations for HLYK.
HLYK vs BUGDF Comparison
HLYK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HLYK stands at 7.05M. In comparison, BUGDF has a market cap of 5.02B. Regarding current trading prices, HLYK is priced at $0.03, while BUGDF trades at $6.31.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HLYK currently has a P/E ratio of -1.25, whereas BUGDF's P/E ratio is 24.27. In terms of profitability, HLYK's ROE is +4.66%, compared to BUGDF's ROE of +0.28%. Regarding short-term risk, HLYK is more volatile compared to BUGDF. This indicates potentially higher risk in terms of short-term price fluctuations for HLYK.
HLYK vs ANHGY Comparison
HLYK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HLYK stands at 7.05M. In comparison, ANHGY has a market cap of 4.05B. Regarding current trading prices, HLYK is priced at $0.03, while ANHGY trades at $5.49.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HLYK currently has a P/E ratio of -1.25, whereas ANHGY's P/E ratio is 23.87. In terms of profitability, HLYK's ROE is +4.66%, compared to ANHGY's ROE of N/A. Regarding short-term risk, HLYK is more volatile compared to ANHGY. This indicates potentially higher risk in terms of short-term price fluctuations for HLYK.
HLYK vs BUHPF Comparison
HLYK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HLYK stands at 7.05M. In comparison, BUHPF has a market cap of 3.86B. Regarding current trading prices, HLYK is priced at $0.03, while BUHPF trades at $4.85.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HLYK currently has a P/E ratio of -1.25, whereas BUHPF's P/E ratio is 18.65. In terms of profitability, HLYK's ROE is +4.66%, compared to BUHPF's ROE of +0.28%. Regarding short-term risk, HLYK is less volatile compared to BUHPF. This indicates potentially lower risk in terms of short-term price fluctuations for HLYK.
HLYK vs MCVEF Comparison
HLYK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HLYK stands at 7.05M. In comparison, MCVEF has a market cap of 2.98B. Regarding current trading prices, HLYK is priced at $0.03, while MCVEF trades at $19.83.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HLYK currently has a P/E ratio of -1.25, whereas MCVEF's P/E ratio is 86.22. In terms of profitability, HLYK's ROE is +4.66%, compared to MCVEF's ROE of +0.06%. Regarding short-term risk, HLYK is more volatile compared to MCVEF. This indicates potentially higher risk in terms of short-term price fluctuations for HLYK.
HLYK vs ORPEF Comparison
HLYK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HLYK stands at 7.05M. In comparison, ORPEF has a market cap of 2.29B. Regarding current trading prices, HLYK is priced at $0.03, while ORPEF trades at $14.22.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HLYK currently has a P/E ratio of -1.25, whereas ORPEF's P/E ratio is 0.03. In terms of profitability, HLYK's ROE is +4.66%, compared to ORPEF's ROE of +0.91%. Regarding short-term risk, HLYK is less volatile compared to ORPEF. This indicates potentially lower risk in terms of short-term price fluctuations for HLYK.
HLYK vs TTALF Comparison
HLYK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HLYK stands at 7.05M. In comparison, TTALF has a market cap of 1.64B. Regarding current trading prices, HLYK is priced at $0.03, while TTALF trades at $12.95.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HLYK currently has a P/E ratio of -1.25, whereas TTALF's P/E ratio is 19.33. In terms of profitability, HLYK's ROE is +4.66%, compared to TTALF's ROE of +0.15%. Regarding short-term risk, HLYK is more volatile compared to TTALF. This indicates potentially higher risk in terms of short-term price fluctuations for HLYK.
HLYK vs RYHTY Comparison
HLYK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HLYK stands at 7.05M. In comparison, RYHTY has a market cap of 1.47B. Regarding current trading prices, HLYK is priced at $0.03, while RYHTY trades at $7.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HLYK currently has a P/E ratio of -1.25, whereas RYHTY's P/E ratio is -20.14. In terms of profitability, HLYK's ROE is +4.66%, compared to RYHTY's ROE of +0.00%. Regarding short-term risk, HLYK is more volatile compared to RYHTY. This indicates potentially higher risk in terms of short-term price fluctuations for HLYK.
HLYK vs RHCGF Comparison
HLYK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HLYK stands at 7.05M. In comparison, RHCGF has a market cap of 1.43B. Regarding current trading prices, HLYK is priced at $0.03, while RHCGF trades at $1.41.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HLYK currently has a P/E ratio of -1.25, whereas RHCGF's P/E ratio is -20.14. In terms of profitability, HLYK's ROE is +4.66%, compared to RHCGF's ROE of -0.02%. Regarding short-term risk, HLYK is less volatile compared to RHCGF. This indicates potentially lower risk in terms of short-term price fluctuations for HLYK.
HLYK vs MCVEY Comparison
HLYK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HLYK stands at 7.05M. In comparison, MCVEY has a market cap of 1.22B. Regarding current trading prices, HLYK is priced at $0.03, while MCVEY trades at $16.55.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HLYK currently has a P/E ratio of -1.25, whereas MCVEY's P/E ratio is 40.37. In terms of profitability, HLYK's ROE is +4.66%, compared to MCVEY's ROE of N/A. Regarding short-term risk, HLYK is more volatile compared to MCVEY. This indicates potentially higher risk in terms of short-term price fluctuations for HLYK.
HLYK vs LTGHF Comparison
HLYK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HLYK stands at 7.05M. In comparison, LTGHF has a market cap of 1.18B. Regarding current trading prices, HLYK is priced at $0.03, while LTGHF trades at $0.82.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HLYK currently has a P/E ratio of -1.25, whereas LTGHF's P/E ratio is 11.70. In terms of profitability, HLYK's ROE is +4.66%, compared to LTGHF's ROE of +0.29%. Regarding short-term risk, HLYK is more volatile compared to LTGHF. This indicates potentially higher risk in terms of short-term price fluctuations for HLYK.
HLYK vs LTGHY Comparison
HLYK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HLYK stands at 7.05M. In comparison, LTGHY has a market cap of 1.17B. Regarding current trading prices, HLYK is priced at $0.03, while LTGHY trades at $3.23.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HLYK currently has a P/E ratio of -1.25, whereas LTGHY's P/E ratio is 10.75. In terms of profitability, HLYK's ROE is +4.66%, compared to LTGHY's ROE of +0.40%. Regarding short-term risk, HLYK is more volatile compared to LTGHY. This indicates potentially higher risk in terms of short-term price fluctuations for HLYK.
HLYK vs LWSCF Comparison
HLYK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HLYK stands at 7.05M. In comparison, LWSCF has a market cap of 1.16B. Regarding current trading prices, HLYK is priced at $0.03, while LWSCF trades at $12.60.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HLYK currently has a P/E ratio of -1.25, whereas LWSCF's P/E ratio is 43.45. In terms of profitability, HLYK's ROE is +4.66%, compared to LWSCF's ROE of +0.09%. Regarding short-term risk, HLYK is more volatile compared to LWSCF. This indicates potentially higher risk in terms of short-term price fluctuations for HLYK.
HLYK vs RAFLF Comparison
HLYK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HLYK stands at 7.05M. In comparison, RAFLF has a market cap of 1.11B. Regarding current trading prices, HLYK is priced at $0.03, while RAFLF trades at $0.60.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HLYK currently has a P/E ratio of -1.25, whereas RAFLF's P/E ratio is 20.00. In terms of profitability, HLYK's ROE is +4.66%, compared to RAFLF's ROE of +0.04%. Regarding short-term risk, HLYK is more volatile compared to RAFLF. This indicates potentially higher risk in terms of short-term price fluctuations for HLYK.
HLYK vs RKAGY Comparison
HLYK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HLYK stands at 7.05M. In comparison, RKAGY has a market cap of 1.05B. Regarding current trading prices, HLYK is priced at $0.03, while RKAGY trades at $7.85.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HLYK currently has a P/E ratio of -1.25, whereas RKAGY's P/E ratio is 21.22. In terms of profitability, HLYK's ROE is +4.66%, compared to RKAGY's ROE of +0.03%. Regarding short-term risk, HLYK is more volatile compared to RKAGY. This indicates potentially higher risk in terms of short-term price fluctuations for HLYK.
HLYK vs RHKJF Comparison
HLYK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HLYK stands at 7.05M. In comparison, RHKJF has a market cap of 1.02B. Regarding current trading prices, HLYK is priced at $0.03, while RHKJF trades at $15.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HLYK currently has a P/E ratio of -1.25, whereas RHKJF's P/E ratio is 21.55. In terms of profitability, HLYK's ROE is +4.66%, compared to RHKJF's ROE of +0.03%. Regarding short-term risk, HLYK is less volatile compared to RHKJF. This indicates potentially lower risk in terms of short-term price fluctuations for HLYK.
HLYK vs NWKHY Comparison
HLYK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HLYK stands at 7.05M. In comparison, NWKHY has a market cap of 945.10M. Regarding current trading prices, HLYK is priced at $0.03, while NWKHY trades at $7.80.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HLYK currently has a P/E ratio of -1.25, whereas NWKHY's P/E ratio is 13.22. In terms of profitability, HLYK's ROE is +4.66%, compared to NWKHY's ROE of +0.13%. Regarding short-term risk, HLYK is more volatile compared to NWKHY. This indicates potentially higher risk in terms of short-term price fluctuations for HLYK.
HLYK vs EXETF Comparison
HLYK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HLYK stands at 7.05M. In comparison, EXETF has a market cap of 862.21M. Regarding current trading prices, HLYK is priced at $0.03, while EXETF trades at $10.33.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HLYK currently has a P/E ratio of -1.25, whereas EXETF's P/E ratio is 16.40. In terms of profitability, HLYK's ROE is +4.66%, compared to EXETF's ROE of +0.69%. Regarding short-term risk, HLYK is more volatile compared to EXETF. This indicates potentially higher risk in terms of short-term price fluctuations for HLYK.
HLYK vs JXFGF Comparison
HLYK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HLYK stands at 7.05M. In comparison, JXFGF has a market cap of 755.56M. Regarding current trading prices, HLYK is priced at $0.03, while JXFGF trades at $0.28.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HLYK currently has a P/E ratio of -1.25, whereas JXFGF's P/E ratio is 14.00. In terms of profitability, HLYK's ROE is +4.66%, compared to JXFGF's ROE of +0.03%. Regarding short-term risk, HLYK is less volatile compared to JXFGF. This indicates potentially lower risk in terms of short-term price fluctuations for HLYK.
HLYK vs WHTCF Comparison
HLYK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HLYK stands at 7.05M. In comparison, WHTCF has a market cap of 749.87M. Regarding current trading prices, HLYK is priced at $0.03, while WHTCF trades at $2.97.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HLYK currently has a P/E ratio of -1.25, whereas WHTCF's P/E ratio is 32.94. In terms of profitability, HLYK's ROE is +4.66%, compared to WHTCF's ROE of +0.04%. Regarding short-term risk, HLYK is more volatile compared to WHTCF. This indicates potentially higher risk in terms of short-term price fluctuations for HLYK.
HLYK vs KDGTF Comparison
HLYK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HLYK stands at 7.05M. In comparison, KDGTF has a market cap of 675.13M. Regarding current trading prices, HLYK is priced at $0.03, while KDGTF trades at $0.68.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HLYK currently has a P/E ratio of -1.25, whereas KDGTF's P/E ratio is -1.67. In terms of profitability, HLYK's ROE is +4.66%, compared to KDGTF's ROE of N/A. Regarding short-term risk, HLYK is more volatile compared to KDGTF. This indicates potentially higher risk in terms of short-term price fluctuations for HLYK.
HLYK vs WFHG Comparison
HLYK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HLYK stands at 7.05M. In comparison, WFHG has a market cap of 470.60M. Regarding current trading prices, HLYK is priced at $0.03, while WFHG trades at $7.41.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HLYK currently has a P/E ratio of -1.25, whereas WFHG's P/E ratio is N/A. In terms of profitability, HLYK's ROE is +4.66%, compared to WFHG's ROE of +0.22%. Regarding short-term risk, HLYK is less volatile compared to WFHG. This indicates potentially lower risk in terms of short-term price fluctuations for HLYK.
HLYK vs ORRRY Comparison
HLYK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HLYK stands at 7.05M. In comparison, ORRRY has a market cap of 371.54M. Regarding current trading prices, HLYK is priced at $0.03, while ORRRY trades at $0.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HLYK currently has a P/E ratio of -1.25, whereas ORRRY's P/E ratio is -0.33. In terms of profitability, HLYK's ROE is +4.66%, compared to ORRRY's ROE of +73.42%. Regarding short-term risk, HLYK is more volatile compared to ORRRY. This indicates potentially higher risk in terms of short-term price fluctuations for HLYK.
HLYK vs BTMDW Comparison
HLYK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HLYK stands at 7.05M. In comparison, BTMDW has a market cap of 292.88M. Regarding current trading prices, HLYK is priced at $0.03, while BTMDW trades at $1.61.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HLYK currently has a P/E ratio of -1.25, whereas BTMDW's P/E ratio is 0.05. In terms of profitability, HLYK's ROE is +4.66%, compared to BTMDW's ROE of -0.19%. Regarding short-term risk, HLYK is more volatile compared to BTMDW. This indicates potentially higher risk in terms of short-term price fluctuations for HLYK.
HLYK vs EVGRF Comparison
HLYK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HLYK stands at 7.05M. In comparison, EVGRF has a market cap of 236.53M. Regarding current trading prices, HLYK is priced at $0.03, while EVGRF trades at $0.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HLYK currently has a P/E ratio of -1.25, whereas EVGRF's P/E ratio is -0.05. In terms of profitability, HLYK's ROE is +4.66%, compared to EVGRF's ROE of +0.67%. Regarding short-term risk, HLYK is less volatile compared to EVGRF. This indicates potentially lower risk in terms of short-term price fluctuations for HLYK.
HLYK vs MKLNF Comparison
HLYK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HLYK stands at 7.05M. In comparison, MKLNF has a market cap of 224.32M. Regarding current trading prices, HLYK is priced at $0.03, while MKLNF trades at $11.73.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HLYK currently has a P/E ratio of -1.25, whereas MKLNF's P/E ratio is 19.23. In terms of profitability, HLYK's ROE is +4.66%, compared to MKLNF's ROE of +0.15%. Regarding short-term risk, HLYK is more volatile compared to MKLNF. This indicates potentially higher risk in terms of short-term price fluctuations for HLYK.
HLYK vs MFCSF Comparison
HLYK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HLYK stands at 7.05M. In comparison, MFCSF has a market cap of 213.42M. Regarding current trading prices, HLYK is priced at $0.03, while MFCSF trades at $11.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HLYK currently has a P/E ratio of -1.25, whereas MFCSF's P/E ratio is 8.16. In terms of profitability, HLYK's ROE is +4.66%, compared to MFCSF's ROE of +0.83%. Regarding short-term risk, HLYK is more volatile compared to MFCSF. This indicates potentially higher risk in terms of short-term price fluctuations for HLYK.
HLYK vs CHHHF Comparison
HLYK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HLYK stands at 7.05M. In comparison, CHHHF has a market cap of 123.47M. Regarding current trading prices, HLYK is priced at $0.03, while CHHHF trades at $1.96.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HLYK currently has a P/E ratio of -1.25, whereas CHHHF's P/E ratio is -39.20. In terms of profitability, HLYK's ROE is +4.66%, compared to CHHHF's ROE of -0.06%. Regarding short-term risk, HLYK is more volatile compared to CHHHF. This indicates potentially higher risk in terms of short-term price fluctuations for HLYK.
HLYK vs VTIAF Comparison
HLYK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HLYK stands at 7.05M. In comparison, VTIAF has a market cap of 104.42M. Regarding current trading prices, HLYK is priced at $0.03, while VTIAF trades at $5.99.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HLYK currently has a P/E ratio of -1.25, whereas VTIAF's P/E ratio is -3.59. In terms of profitability, HLYK's ROE is +4.66%, compared to VTIAF's ROE of +0.11%. Regarding short-term risk, HLYK is more volatile compared to VTIAF. This indicates potentially higher risk in terms of short-term price fluctuations for HLYK.
HLYK vs MCIOF Comparison
HLYK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HLYK stands at 7.05M. In comparison, MCIOF has a market cap of 54.04M. Regarding current trading prices, HLYK is priced at $0.03, while MCIOF trades at $0.55.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HLYK currently has a P/E ratio of -1.25, whereas MCIOF's P/E ratio is -1.22. In terms of profitability, HLYK's ROE is +4.66%, compared to MCIOF's ROE of N/A. Regarding short-term risk, HLYK is more volatile compared to MCIOF. This indicates potentially higher risk in terms of short-term price fluctuations for HLYK.
HLYK vs ASSF Comparison
HLYK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HLYK stands at 7.05M. In comparison, ASSF has a market cap of 45.35M. Regarding current trading prices, HLYK is priced at $0.03, while ASSF trades at $1.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HLYK currently has a P/E ratio of -1.25, whereas ASSF's P/E ratio is -33.33. In terms of profitability, HLYK's ROE is +4.66%, compared to ASSF's ROE of -6.63%. Regarding short-term risk, HLYK is more volatile compared to ASSF. This indicates potentially higher risk in terms of short-term price fluctuations for HLYK.
HLYK vs KONEF Comparison
HLYK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HLYK stands at 7.05M. In comparison, KONEF has a market cap of 44.34M. Regarding current trading prices, HLYK is priced at $0.03, while KONEF trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HLYK currently has a P/E ratio of -1.25, whereas KONEF's P/E ratio is N/A. In terms of profitability, HLYK's ROE is +4.66%, compared to KONEF's ROE of -6.56%. Regarding short-term risk, HLYK is less volatile compared to KONEF. This indicates potentially lower risk in terms of short-term price fluctuations for HLYK.
HLYK vs HQDA Comparison
HLYK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HLYK stands at 7.05M. In comparison, HQDA has a market cap of 18.64M. Regarding current trading prices, HLYK is priced at $0.03, while HQDA trades at $0.13.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HLYK currently has a P/E ratio of -1.25, whereas HQDA's P/E ratio is N/A. In terms of profitability, HLYK's ROE is +4.66%, compared to HQDA's ROE of +0.00%. Regarding short-term risk, HLYK is more volatile compared to HQDA. This indicates potentially higher risk in terms of short-term price fluctuations for HLYK.
HLYK vs USNU Comparison
HLYK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HLYK stands at 7.05M. In comparison, USNU has a market cap of 17.13M. Regarding current trading prices, HLYK is priced at $0.03, while USNU trades at $0.80.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HLYK currently has a P/E ratio of -1.25, whereas USNU's P/E ratio is -6.15. In terms of profitability, HLYK's ROE is +4.66%, compared to USNU's ROE of -0.81%. Regarding short-term risk, HLYK is more volatile compared to USNU. This indicates potentially higher risk in terms of short-term price fluctuations for HLYK.
HLYK vs NVLPF Comparison
HLYK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HLYK stands at 7.05M. In comparison, NVLPF has a market cap of 16.21M. Regarding current trading prices, HLYK is priced at $0.03, while NVLPF trades at $0.19.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HLYK currently has a P/E ratio of -1.25, whereas NVLPF's P/E ratio is 9.28. In terms of profitability, HLYK's ROE is +4.66%, compared to NVLPF's ROE of +0.08%. Regarding short-term risk, HLYK is more volatile compared to NVLPF. This indicates potentially higher risk in terms of short-term price fluctuations for HLYK.
HLYK vs FPCG Comparison
HLYK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HLYK stands at 7.05M. In comparison, FPCG has a market cap of 10.25M. Regarding current trading prices, HLYK is priced at $0.03, while FPCG trades at $1,025.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HLYK currently has a P/E ratio of -1.25, whereas FPCG's P/E ratio is 0.09. In terms of profitability, HLYK's ROE is +4.66%, compared to FPCG's ROE of +0.00%. Regarding short-term risk, HLYK is more volatile compared to FPCG. This indicates potentially higher risk in terms of short-term price fluctuations for HLYK.
HLYK vs XCRT Comparison
HLYK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HLYK stands at 7.05M. In comparison, XCRT has a market cap of 8.54M. Regarding current trading prices, HLYK is priced at $0.03, while XCRT trades at $0.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HLYK currently has a P/E ratio of -1.25, whereas XCRT's P/E ratio is N/A. In terms of profitability, HLYK's ROE is +4.66%, compared to XCRT's ROE of +2.48%. Regarding short-term risk, HLYK is more volatile compared to XCRT. This indicates potentially higher risk in terms of short-term price fluctuations for HLYK.
HLYK vs NUMIF Comparison
HLYK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HLYK stands at 7.05M. In comparison, NUMIF has a market cap of 6.53M. Regarding current trading prices, HLYK is priced at $0.03, while NUMIF trades at $0.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HLYK currently has a P/E ratio of -1.25, whereas NUMIF's P/E ratio is -0.33. In terms of profitability, HLYK's ROE is +4.66%, compared to NUMIF's ROE of -1.95%. Regarding short-term risk, HLYK is more volatile compared to NUMIF. This indicates potentially higher risk in terms of short-term price fluctuations for HLYK.
HLYK vs GBCS Comparison
HLYK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HLYK stands at 7.05M. In comparison, GBCS has a market cap of 6.13M. Regarding current trading prices, HLYK is priced at $0.03, while GBCS trades at $2.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HLYK currently has a P/E ratio of -1.25, whereas GBCS's P/E ratio is -2.50. In terms of profitability, HLYK's ROE is +4.66%, compared to GBCS's ROE of +0.56%. Regarding short-term risk, HLYK is more volatile compared to GBCS. This indicates potentially higher risk in terms of short-term price fluctuations for HLYK.
HLYK vs VLXC Comparison
HLYK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HLYK stands at 7.05M. In comparison, VLXC has a market cap of 5.01M. Regarding current trading prices, HLYK is priced at $0.03, while VLXC trades at $0.07.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HLYK currently has a P/E ratio of -1.25, whereas VLXC's P/E ratio is -7.00. In terms of profitability, HLYK's ROE is +4.66%, compared to VLXC's ROE of +0.68%. Regarding short-term risk, HLYK is more volatile compared to VLXC. This indicates potentially higher risk in terms of short-term price fluctuations for HLYK.
HLYK vs BICX Comparison
HLYK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HLYK stands at 7.05M. In comparison, BICX has a market cap of 5.01M. Regarding current trading prices, HLYK is priced at $0.03, while BICX trades at $0.31.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HLYK currently has a P/E ratio of -1.25, whereas BICX's P/E ratio is -0.63. In terms of profitability, HLYK's ROE is +4.66%, compared to BICX's ROE of +0.45%. Regarding short-term risk, HLYK is more volatile compared to BICX. This indicates potentially higher risk in terms of short-term price fluctuations for HLYK.
HLYK vs RHEP Comparison
HLYK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HLYK stands at 7.05M. In comparison, RHEP has a market cap of 4.64M. Regarding current trading prices, HLYK is priced at $0.03, while RHEP trades at $2.18.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HLYK currently has a P/E ratio of -1.25, whereas RHEP's P/E ratio is -1.26. In terms of profitability, HLYK's ROE is +4.66%, compared to RHEP's ROE of N/A. Regarding short-term risk, HLYK is more volatile compared to RHEP. This indicates potentially higher risk in terms of short-term price fluctuations for HLYK.
HLYK vs GRST Comparison
HLYK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HLYK stands at 7.05M. In comparison, GRST has a market cap of 2.71M. Regarding current trading prices, HLYK is priced at $0.03, while GRST trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HLYK currently has a P/E ratio of -1.25, whereas GRST's P/E ratio is N/A. In terms of profitability, HLYK's ROE is +4.66%, compared to GRST's ROE of +0.30%. Regarding short-term risk, HLYK is more volatile compared to GRST. This indicates potentially higher risk in terms of short-term price fluctuations for HLYK.
HLYK vs EPWCF Comparison
HLYK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HLYK stands at 7.05M. In comparison, EPWCF has a market cap of 2.54M. Regarding current trading prices, HLYK is priced at $0.03, while EPWCF trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HLYK currently has a P/E ratio of -1.25, whereas EPWCF's P/E ratio is N/A. In terms of profitability, HLYK's ROE is +4.66%, compared to EPWCF's ROE of +0.00%. Regarding short-term risk, HLYK is less volatile compared to EPWCF. This indicates potentially lower risk in terms of short-term price fluctuations for HLYK.
HLYK vs JRSS Comparison
HLYK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HLYK stands at 7.05M. In comparison, JRSS has a market cap of 2.09M. Regarding current trading prices, HLYK is priced at $0.03, while JRSS trades at $0.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HLYK currently has a P/E ratio of -1.25, whereas JRSS's P/E ratio is -0.41. In terms of profitability, HLYK's ROE is +4.66%, compared to JRSS's ROE of +2.63%. Regarding short-term risk, HLYK is more volatile compared to JRSS. This indicates potentially higher risk in terms of short-term price fluctuations for HLYK.
HLYK vs TOKIF Comparison
HLYK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HLYK stands at 7.05M. In comparison, TOKIF has a market cap of 1.78M. Regarding current trading prices, HLYK is priced at $0.03, while TOKIF trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HLYK currently has a P/E ratio of -1.25, whereas TOKIF's P/E ratio is -0.01. In terms of profitability, HLYK's ROE is +4.66%, compared to TOKIF's ROE of -0.83%. Regarding short-term risk, HLYK is less volatile compared to TOKIF. This indicates potentially lower risk in terms of short-term price fluctuations for HLYK.
HLYK vs SMAS Comparison
HLYK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HLYK stands at 7.05M. In comparison, SMAS has a market cap of 1.46M. Regarding current trading prices, HLYK is priced at $0.03, while SMAS trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HLYK currently has a P/E ratio of -1.25, whereas SMAS's P/E ratio is N/A. In terms of profitability, HLYK's ROE is +4.66%, compared to SMAS's ROE of N/A. Regarding short-term risk, HLYK is less volatile compared to SMAS. This indicates potentially lower risk in terms of short-term price fluctuations for HLYK.
HLYK vs MDGP Comparison
HLYK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HLYK stands at 7.05M. In comparison, MDGP has a market cap of 1.45M. Regarding current trading prices, HLYK is priced at $0.03, while MDGP trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HLYK currently has a P/E ratio of -1.25, whereas MDGP's P/E ratio is N/A. In terms of profitability, HLYK's ROE is +4.66%, compared to MDGP's ROE of N/A. Regarding short-term risk, HLYK is more volatile compared to MDGP. This indicates potentially higher risk in terms of short-term price fluctuations for HLYK.
HLYK vs NOVC Comparison
HLYK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HLYK stands at 7.05M. In comparison, NOVC has a market cap of 1.16M. Regarding current trading prices, HLYK is priced at $0.03, while NOVC trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HLYK currently has a P/E ratio of -1.25, whereas NOVC's P/E ratio is -0.20. In terms of profitability, HLYK's ROE is +4.66%, compared to NOVC's ROE of +0.12%. Regarding short-term risk, HLYK is more volatile compared to NOVC. This indicates potentially higher risk in terms of short-term price fluctuations for HLYK.
HLYK vs PHMB Comparison
HLYK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HLYK stands at 7.05M. In comparison, PHMB has a market cap of 1.08M. Regarding current trading prices, HLYK is priced at $0.03, while PHMB trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HLYK currently has a P/E ratio of -1.25, whereas PHMB's P/E ratio is N/A. In terms of profitability, HLYK's ROE is +4.66%, compared to PHMB's ROE of N/A. Regarding short-term risk, HLYK is less volatile compared to PHMB. This indicates potentially lower risk in terms of short-term price fluctuations for HLYK.
HLYK vs GNOW Comparison
HLYK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HLYK stands at 7.05M. In comparison, GNOW has a market cap of 859731.00. Regarding current trading prices, HLYK is priced at $0.03, while GNOW trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HLYK currently has a P/E ratio of -1.25, whereas GNOW's P/E ratio is -0.01. In terms of profitability, HLYK's ROE is +4.66%, compared to GNOW's ROE of +0.00%. Regarding short-term risk, HLYK is more volatile compared to GNOW. This indicates potentially higher risk in terms of short-term price fluctuations for HLYK.
HLYK vs DPAT Comparison
HLYK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HLYK stands at 7.05M. In comparison, DPAT has a market cap of 397353.00. Regarding current trading prices, HLYK is priced at $0.03, while DPAT trades at $0.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HLYK currently has a P/E ratio of -1.25, whereas DPAT's P/E ratio is -1.65. In terms of profitability, HLYK's ROE is +4.66%, compared to DPAT's ROE of +0.45%. Regarding short-term risk, HLYK is more volatile compared to DPAT. This indicates potentially higher risk in terms of short-term price fluctuations for HLYK.
HLYK vs ARPC Comparison
HLYK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HLYK stands at 7.05M. In comparison, ARPC has a market cap of 336555.00. Regarding current trading prices, HLYK is priced at $0.03, while ARPC trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HLYK currently has a P/E ratio of -1.25, whereas ARPC's P/E ratio is N/A. In terms of profitability, HLYK's ROE is +4.66%, compared to ARPC's ROE of -0.56%. Regarding short-term risk, HLYK is less volatile compared to ARPC. This indicates potentially lower risk in terms of short-term price fluctuations for HLYK.
HLYK vs NXGT Comparison
HLYK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HLYK stands at 7.05M. In comparison, NXGT has a market cap of 332870.00. Regarding current trading prices, HLYK is priced at $0.03, while NXGT trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HLYK currently has a P/E ratio of -1.25, whereas NXGT's P/E ratio is N/A. In terms of profitability, HLYK's ROE is +4.66%, compared to NXGT's ROE of +0.09%. Regarding short-term risk, HLYK is more volatile compared to NXGT. This indicates potentially higher risk in terms of short-term price fluctuations for HLYK.
HLYK vs JNHMF Comparison
HLYK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HLYK stands at 7.05M. In comparison, JNHMF has a market cap of 315304.00. Regarding current trading prices, HLYK is priced at $0.03, while JNHMF trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HLYK currently has a P/E ratio of -1.25, whereas JNHMF's P/E ratio is -0.07. In terms of profitability, HLYK's ROE is +4.66%, compared to JNHMF's ROE of +0.81%. Regarding short-term risk, HLYK is more volatile compared to JNHMF. This indicates potentially higher risk in terms of short-term price fluctuations for HLYK.
HLYK vs KJFI Comparison
HLYK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HLYK stands at 7.05M. In comparison, KJFI has a market cap of 278854.00. Regarding current trading prices, HLYK is priced at $0.03, while KJFI trades at $0.13.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HLYK currently has a P/E ratio of -1.25, whereas KJFI's P/E ratio is -0.06. In terms of profitability, HLYK's ROE is +4.66%, compared to KJFI's ROE of +0.00%. Regarding short-term risk, HLYK is more volatile compared to KJFI. This indicates potentially higher risk in terms of short-term price fluctuations for HLYK.
HLYK vs FCHS Comparison
HLYK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HLYK stands at 7.05M. In comparison, FCHS has a market cap of 263666.00. Regarding current trading prices, HLYK is priced at $0.03, while FCHS trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HLYK currently has a P/E ratio of -1.25, whereas FCHS's P/E ratio is -0.07. In terms of profitability, HLYK's ROE is +4.66%, compared to FCHS's ROE of +0.12%. Regarding short-term risk, HLYK is less volatile compared to FCHS. This indicates potentially lower risk in terms of short-term price fluctuations for HLYK.
HLYK vs HSMD Comparison
HLYK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HLYK stands at 7.05M. In comparison, HSMD has a market cap of 153388.00. Regarding current trading prices, HLYK is priced at $0.03, while HSMD trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HLYK currently has a P/E ratio of -1.25, whereas HSMD's P/E ratio is -0.05. In terms of profitability, HLYK's ROE is +4.66%, compared to HSMD's ROE of -0.04%. Regarding short-term risk, HLYK is more volatile compared to HSMD. This indicates potentially higher risk in terms of short-term price fluctuations for HLYK.
HLYK vs SETO Comparison
HLYK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HLYK stands at 7.05M. In comparison, SETO has a market cap of 150935.00. Regarding current trading prices, HLYK is priced at $0.03, while SETO trades at $0.03.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HLYK currently has a P/E ratio of -1.25, whereas SETO's P/E ratio is -2.94. In terms of profitability, HLYK's ROE is +4.66%, compared to SETO's ROE of +0.00%. Regarding short-term risk, HLYK is more volatile compared to SETO. This indicates potentially higher risk in terms of short-term price fluctuations for HLYK.
HLYK vs BNYN Comparison
HLYK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HLYK stands at 7.05M. In comparison, BNYN has a market cap of 150549.00. Regarding current trading prices, HLYK is priced at $0.03, while BNYN trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HLYK currently has a P/E ratio of -1.25, whereas BNYN's P/E ratio is N/A. In terms of profitability, HLYK's ROE is +4.66%, compared to BNYN's ROE of -14.10%. Regarding short-term risk, HLYK is less volatile compared to BNYN. This indicates potentially lower risk in terms of short-term price fluctuations for HLYK.
HLYK vs TPIA Comparison
HLYK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HLYK stands at 7.05M. In comparison, TPIA has a market cap of 113827.00. Regarding current trading prices, HLYK is priced at $0.03, while TPIA trades at $0.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HLYK currently has a P/E ratio of -1.25, whereas TPIA's P/E ratio is -0.15. In terms of profitability, HLYK's ROE is +4.66%, compared to TPIA's ROE of +0.61%. Regarding short-term risk, HLYK is less volatile compared to TPIA. This indicates potentially lower risk in terms of short-term price fluctuations for HLYK.
HLYK vs COLRF Comparison
HLYK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HLYK stands at 7.05M. In comparison, COLRF has a market cap of 108333.00. Regarding current trading prices, HLYK is priced at $0.03, while COLRF trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HLYK currently has a P/E ratio of -1.25, whereas COLRF's P/E ratio is -0.01. In terms of profitability, HLYK's ROE is +4.66%, compared to COLRF's ROE of +0.02%. Regarding short-term risk, HLYK is more volatile compared to COLRF. This indicates potentially higher risk in terms of short-term price fluctuations for HLYK.
HLYK vs AMBD Comparison
HLYK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HLYK stands at 7.05M. In comparison, AMBD has a market cap of 85625.00. Regarding current trading prices, HLYK is priced at $0.03, while AMBD trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HLYK currently has a P/E ratio of -1.25, whereas AMBD's P/E ratio is N/A. In terms of profitability, HLYK's ROE is +4.66%, compared to AMBD's ROE of N/A. Regarding short-term risk, HLYK is less volatile compared to AMBD. This indicates potentially lower risk in terms of short-term price fluctuations for HLYK.
HLYK vs NMHLY Comparison
HLYK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HLYK stands at 7.05M. In comparison, NMHLY has a market cap of 41741.00. Regarding current trading prices, HLYK is priced at $0.03, while NMHLY trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HLYK currently has a P/E ratio of -1.25, whereas NMHLY's P/E ratio is 0.02. In terms of profitability, HLYK's ROE is +4.66%, compared to NMHLY's ROE of N/A. Regarding short-term risk, HLYK is more volatile compared to NMHLY. This indicates potentially higher risk in terms of short-term price fluctuations for HLYK.
HLYK vs GENN Comparison
HLYK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HLYK stands at 7.05M. In comparison, GENN has a market cap of 32696.00. Regarding current trading prices, HLYK is priced at $0.03, while GENN trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HLYK currently has a P/E ratio of -1.25, whereas GENN's P/E ratio is -0.02. In terms of profitability, HLYK's ROE is +4.66%, compared to GENN's ROE of +0.00%. Regarding short-term risk, HLYK is more volatile compared to GENN. This indicates potentially higher risk in terms of short-term price fluctuations for HLYK.
HLYK vs DRWN Comparison
HLYK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HLYK stands at 7.05M. In comparison, DRWN has a market cap of 23978.00. Regarding current trading prices, HLYK is priced at $0.03, while DRWN trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HLYK currently has a P/E ratio of -1.25, whereas DRWN's P/E ratio is N/A. In terms of profitability, HLYK's ROE is +4.66%, compared to DRWN's ROE of -0.01%. Regarding short-term risk, HLYK is less volatile compared to DRWN. This indicates potentially lower risk in terms of short-term price fluctuations for HLYK.
HLYK vs CLRD Comparison
HLYK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HLYK stands at 7.05M. In comparison, CLRD has a market cap of 21647.00. Regarding current trading prices, HLYK is priced at $0.03, while CLRD trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HLYK currently has a P/E ratio of -1.25, whereas CLRD's P/E ratio is N/A. In terms of profitability, HLYK's ROE is +4.66%, compared to CLRD's ROE of +0.38%. Regarding short-term risk, HLYK is more volatile compared to CLRD. This indicates potentially higher risk in terms of short-term price fluctuations for HLYK.
HLYK vs SCAL Comparison
HLYK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HLYK stands at 7.05M. In comparison, SCAL has a market cap of 17424.00. Regarding current trading prices, HLYK is priced at $0.03, while SCAL trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HLYK currently has a P/E ratio of -1.25, whereas SCAL's P/E ratio is 0.04. In terms of profitability, HLYK's ROE is +4.66%, compared to SCAL's ROE of +0.07%. Regarding short-term risk, HLYK is more volatile compared to SCAL. This indicates potentially higher risk in terms of short-term price fluctuations for HLYK.
HLYK vs CHCR Comparison
HLYK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HLYK stands at 7.05M. In comparison, CHCR has a market cap of 11991.00. Regarding current trading prices, HLYK is priced at $0.03, while CHCR trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HLYK currently has a P/E ratio of -1.25, whereas CHCR's P/E ratio is -0.00. In terms of profitability, HLYK's ROE is +4.66%, compared to CHCR's ROE of N/A. Regarding short-term risk, HLYK is more volatile compared to CHCR. This indicates potentially higher risk in terms of short-term price fluctuations for HLYK.
HLYK vs ACGI Comparison
HLYK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HLYK stands at 7.05M. In comparison, ACGI has a market cap of 10477.00. Regarding current trading prices, HLYK is priced at $0.03, while ACGI trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HLYK currently has a P/E ratio of -1.25, whereas ACGI's P/E ratio is N/A. In terms of profitability, HLYK's ROE is +4.66%, compared to ACGI's ROE of +1.11%. Regarding short-term risk, HLYK is less volatile compared to ACGI. This indicates potentially lower risk in terms of short-term price fluctuations for HLYK.
HLYK vs CEVE Comparison
HLYK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HLYK stands at 7.05M. In comparison, CEVE has a market cap of 7709.00. Regarding current trading prices, HLYK is priced at $0.03, while CEVE trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HLYK currently has a P/E ratio of -1.25, whereas CEVE's P/E ratio is N/A. In terms of profitability, HLYK's ROE is +4.66%, compared to CEVE's ROE of N/A. Regarding short-term risk, HLYK is more volatile compared to CEVE. This indicates potentially higher risk in terms of short-term price fluctuations for HLYK.
HLYK vs NAFS Comparison
HLYK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HLYK stands at 7.05M. In comparison, NAFS has a market cap of 7007.00. Regarding current trading prices, HLYK is priced at $0.03, while NAFS trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HLYK currently has a P/E ratio of -1.25, whereas NAFS's P/E ratio is N/A. In terms of profitability, HLYK's ROE is +4.66%, compared to NAFS's ROE of +1.02%. Regarding short-term risk, HLYK is more volatile compared to NAFS. This indicates potentially higher risk in terms of short-term price fluctuations for HLYK.
HLYK vs PRMD Comparison
HLYK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HLYK stands at 7.05M. In comparison, PRMD has a market cap of 5610.00. Regarding current trading prices, HLYK is priced at $0.03, while PRMD trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HLYK currently has a P/E ratio of -1.25, whereas PRMD's P/E ratio is N/A. In terms of profitability, HLYK's ROE is +4.66%, compared to PRMD's ROE of +0.73%. Regarding short-term risk, HLYK is less volatile compared to PRMD. This indicates potentially lower risk in terms of short-term price fluctuations for HLYK.
HLYK vs MSGP Comparison
HLYK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HLYK stands at 7.05M. In comparison, MSGP has a market cap of 5191.00. Regarding current trading prices, HLYK is priced at $0.03, while MSGP trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HLYK currently has a P/E ratio of -1.25, whereas MSGP's P/E ratio is N/A. In terms of profitability, HLYK's ROE is +4.66%, compared to MSGP's ROE of +0.27%. Regarding short-term risk, HLYK is more volatile compared to MSGP. This indicates potentially higher risk in terms of short-term price fluctuations for HLYK.
HLYK vs MSITF Comparison
HLYK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HLYK stands at 7.05M. In comparison, MSITF has a market cap of 4800.00. Regarding current trading prices, HLYK is priced at $0.03, while MSITF trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HLYK currently has a P/E ratio of -1.25, whereas MSITF's P/E ratio is -0.00. In terms of profitability, HLYK's ROE is +4.66%, compared to MSITF's ROE of N/A. Regarding short-term risk, HLYK is more volatile compared to MSITF. This indicates potentially higher risk in terms of short-term price fluctuations for HLYK.
HLYK vs ERUC Comparison
HLYK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HLYK stands at 7.05M. In comparison, ERUC has a market cap of 3915.00. Regarding current trading prices, HLYK is priced at $0.03, while ERUC trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HLYK currently has a P/E ratio of -1.25, whereas ERUC's P/E ratio is N/A. In terms of profitability, HLYK's ROE is +4.66%, compared to ERUC's ROE of N/A. Regarding short-term risk, HLYK is less volatile compared to ERUC. This indicates potentially lower risk in terms of short-term price fluctuations for HLYK.
HLYK vs SLHPF Comparison
HLYK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HLYK stands at 7.05M. In comparison, SLHPF has a market cap of 3901.00. Regarding current trading prices, HLYK is priced at $0.03, while SLHPF trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HLYK currently has a P/E ratio of -1.25, whereas SLHPF's P/E ratio is N/A. In terms of profitability, HLYK's ROE is +4.66%, compared to SLHPF's ROE of +0.00%. Regarding short-term risk, HLYK is less volatile compared to SLHPF. This indicates potentially lower risk in terms of short-term price fluctuations for HLYK.
HLYK vs WEQL Comparison
HLYK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HLYK stands at 7.05M. In comparison, WEQL has a market cap of 3534.00. Regarding current trading prices, HLYK is priced at $0.03, while WEQL trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HLYK currently has a P/E ratio of -1.25, whereas WEQL's P/E ratio is N/A. In terms of profitability, HLYK's ROE is +4.66%, compared to WEQL's ROE of N/A. Regarding short-term risk, HLYK is more volatile compared to WEQL. This indicates potentially higher risk in terms of short-term price fluctuations for HLYK.
HLYK vs BBAL Comparison
HLYK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HLYK stands at 7.05M. In comparison, BBAL has a market cap of 3354.00. Regarding current trading prices, HLYK is priced at $0.03, while BBAL trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HLYK currently has a P/E ratio of -1.25, whereas BBAL's P/E ratio is N/A. In terms of profitability, HLYK's ROE is +4.66%, compared to BBAL's ROE of N/A. Regarding short-term risk, HLYK is more volatile compared to BBAL. This indicates potentially higher risk in terms of short-term price fluctuations for HLYK.
HLYK vs PAOG Comparison
HLYK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HLYK stands at 7.05M. In comparison, PAOG has a market cap of 2478.00. Regarding current trading prices, HLYK is priced at $0.03, while PAOG trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HLYK currently has a P/E ratio of -1.25, whereas PAOG's P/E ratio is N/A. In terms of profitability, HLYK's ROE is +4.66%, compared to PAOG's ROE of +0.08%. Regarding short-term risk, HLYK is less volatile compared to PAOG. This indicates potentially lower risk in terms of short-term price fluctuations for HLYK.
HLYK vs NMMCF Comparison
HLYK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HLYK stands at 7.05M. In comparison, NMMCF has a market cap of 2087.00. Regarding current trading prices, HLYK is priced at $0.03, while NMMCF trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HLYK currently has a P/E ratio of -1.25, whereas NMMCF's P/E ratio is 0.00. In terms of profitability, HLYK's ROE is +4.66%, compared to NMMCF's ROE of +0.00%. Regarding short-term risk, HLYK is less volatile compared to NMMCF. This indicates potentially lower risk in terms of short-term price fluctuations for HLYK.
HLYK vs PPRG Comparison
HLYK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HLYK stands at 7.05M. In comparison, PPRG has a market cap of 1580.00. Regarding current trading prices, HLYK is priced at $0.03, while PPRG trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HLYK currently has a P/E ratio of -1.25, whereas PPRG's P/E ratio is N/A. In terms of profitability, HLYK's ROE is +4.66%, compared to PPRG's ROE of N/A. Regarding short-term risk, HLYK is more volatile compared to PPRG. This indicates potentially higher risk in terms of short-term price fluctuations for HLYK.
HLYK vs OHAQ Comparison
HLYK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HLYK stands at 7.05M. In comparison, OHAQ has a market cap of 1375.00. Regarding current trading prices, HLYK is priced at $0.03, while OHAQ trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HLYK currently has a P/E ratio of -1.25, whereas OHAQ's P/E ratio is 0.01. In terms of profitability, HLYK's ROE is +4.66%, compared to OHAQ's ROE of N/A. Regarding short-term risk, HLYK is more volatile compared to OHAQ. This indicates potentially higher risk in terms of short-term price fluctuations for HLYK.
HLYK vs BNKL Comparison
HLYK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HLYK stands at 7.05M. In comparison, BNKL has a market cap of 1248.00. Regarding current trading prices, HLYK is priced at $0.03, while BNKL trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HLYK currently has a P/E ratio of -1.25, whereas BNKL's P/E ratio is N/A. In terms of profitability, HLYK's ROE is +4.66%, compared to BNKL's ROE of -7.69%. Regarding short-term risk, HLYK is more volatile compared to BNKL. This indicates potentially higher risk in terms of short-term price fluctuations for HLYK.
HLYK vs MAHN Comparison
HLYK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HLYK stands at 7.05M. In comparison, MAHN has a market cap of 1211.00. Regarding current trading prices, HLYK is priced at $0.03, while MAHN trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HLYK currently has a P/E ratio of -1.25, whereas MAHN's P/E ratio is 0.05. In terms of profitability, HLYK's ROE is +4.66%, compared to MAHN's ROE of N/A. Regarding short-term risk, HLYK is less volatile compared to MAHN. This indicates potentially lower risk in terms of short-term price fluctuations for HLYK.
HLYK vs SLHGF Comparison
HLYK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HLYK stands at 7.05M. In comparison, SLHGF has a market cap of 398.00. Regarding current trading prices, HLYK is priced at $0.03, while SLHGF trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HLYK currently has a P/E ratio of -1.25, whereas SLHGF's P/E ratio is -0.00. In terms of profitability, HLYK's ROE is +4.66%, compared to SLHGF's ROE of +0.00%. Regarding short-term risk, HLYK is more volatile compared to SLHGF. This indicates potentially higher risk in terms of short-term price fluctuations for HLYK.
HLYK vs LHRP Comparison
HLYK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HLYK stands at 7.05M. In comparison, LHRP has a market cap of 340.00. Regarding current trading prices, HLYK is priced at $0.03, while LHRP trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HLYK currently has a P/E ratio of -1.25, whereas LHRP's P/E ratio is 0.00. In terms of profitability, HLYK's ROE is +4.66%, compared to LHRP's ROE of N/A. Regarding short-term risk, HLYK is more volatile compared to LHRP. This indicates potentially higher risk in terms of short-term price fluctuations for HLYK.
HLYK vs NMSCA Comparison
HLYK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HLYK stands at 7.05M. In comparison, NMSCA has a market cap of 275.00. Regarding current trading prices, HLYK is priced at $0.03, while NMSCA trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HLYK currently has a P/E ratio of -1.25, whereas NMSCA's P/E ratio is N/A. In terms of profitability, HLYK's ROE is +4.66%, compared to NMSCA's ROE of N/A. Regarding short-term risk, HLYK is more volatile compared to NMSCA. This indicates potentially higher risk in terms of short-term price fluctuations for HLYK.